CHEN YU of PALO ALTO, CA appears across SEC filings — Form ADV advisers, Form D, Reg A, and crowdfunding offerings. CHEN YU appears on 15 filing roles across Form D (13), Form ADV (2).
| Filed | Source | Entity | Role | Location |
|---|---|---|---|---|
| — | Form ADV | VISION INVESTMENT MANAGEMENT (ASIA) LIMITED | CHIEF OPERATIONS OFFICER | HONG KONG SAR |
| — | Form ADV | VISION INVESTMENT MANAGEMENT (BVI) LIMITED | CHIEF COMPLIANCE OFFICER | ROAD TOWN, TORTOLA |
| 2010-09-14 | Form D | Sagent Holding Co. | Director | SCHAUMBURG, IL |
| 2009-04-13 | Form D | Nora Therapeutics, Inc. | Director | PALO ALTO, CA |
| 2016-10-18 | Form D | SentreHEART Inc | Director | REDWOOD CITY, CA |
| 2015-06-23 | Form D | Nexcida Therapeutics, Inc. | Director | MENLO PARK, CA |
| 2024-01-10 | Form D | LB PHARMACEUTICALS INC | Director | NEW YORK, NY |
| 2021-11-10 | Form D | Arbor Biotechnologies, Inc. | Director | CAMBRIDGE, MA |
| 2019-10-30 | Form D | Vivo Capital Fund IX, L.P. | Director | PALO ALTO, CA |
| 2019-09-27 | Form D | Vivo Capital Fund IX E&F, L.P. | Executive Officer | PALO ALTO, CA |
| 2023-08-10 | Form D | ADARx Pharmaceuticals, Inc. | Director | San Diego, CA |
| 2021-04-14 | Form D | TCG Crossover Fund I, L.P. | Executive Officer | PALO ALTO, CA |
| 2023-04-06 | Form D | TCG Crossover Fund II, L.P. | Executive Officer | PALO ALTO, CA |
| 2025-06-26 | Form D | TCG Crossover Fund III, L.P. | Executive Officer | PALO ALTO, CA |
| 2026-07-29 | Form D | TCGX Asia Life Sciences Fund I, L.P. | Related Person | PALO ALTO, CA |